For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Aptamers are a small segment of oligonucleotides screened in vitro and can be highly affinity and strong with the corresponding ligands.
Scope of the Report:
This report focuses on the Aptamer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The combination of the opposite sex, its appearance provides a new research platform for high efficiency and fast recognition for the chemical and biomedical circles, and has shown good prospects in many aspects.
Nucleic acid aptamers are highly specific and highly selective in combination with a variety of target substances and are therefore widely used in the field of biosensors. When a nucleic acid aptamer specifically binds to a target substance, the configuration of the nucleic acid aptamer itself changes. Researchers have applied nucleic acid aptamers to probes and developed many electrochemical sensors based on the configuration changes of nucleic acid aptamers, also known as E-AB (Electrochemical aptamer-based) sensors, combined with electrochemical detection methods. The E-AB sensor improves the application of nucleic acid aptamers in the sensor field because of its portability, simple operation and low cost.
The worldwide market for Aptamer is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 440 million US$ in 2023, from 260 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- NewVentures Biotechnology
- Aptamer Science
- Aptagen
- Aptamer Group
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Nucleic acid Aptamer
- Peptide Aptamer
Market Segment by Applications, can be divided into
- Research, Diagnostics
- Therapeutics
There are 15 Chapters to deeply display the global Aptamer market.
Chapter 1, to describe Aptamer Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Aptamer, with sales, revenue, and price of Aptamer, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Aptamer, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Aptamer market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Aptamer sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source